Publication: 2718

Placebo-Controlled Trial to Determine the Effectiveness of a Urea/Lactic Acid–Based Topical Keratolytic Agent for Prevention of Capecitabine-Induced Hand-Foot Syndrome: North Central Cancer Treatment Group Study N05C5
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 28 (35) 5182-5187
Year:
2010
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
831  
Children:
None
Program:
CCP
Primary Committee:
Symptom Inter
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA035267, CA-03011, U10 CA052352, U10 CA037417, N01 CA035431, U10 CA035269, CA-37404, CA-95968, CA-35090, K05 CA124477, CA-52352, CA-35195, CA-67753, U10 CA037404, N01 CA035119, U10 CA035448, U10 CA035195, U10 CA114558, CA-35103, CA-25224, CA-124477, U10 CA095968, CA-35113, U10 CA035101, U10 CA035113, U10 CA035415, U10 CA063849, U10 CA067575, CA-35415, U10 CA035431, U10 CA035119, CA-37417, CA-35269, CA-35448, N01 CA067575, CA-35101, U10 CA025224, CA-114558, U10 CA035090, U10 CA067753, CA-35267, CA-63849, U10 CA035103  
Corr. Author:
Sherry L. Wolf 
Authors:
                       
Networks:
 
Study
NCCTG-N05C5
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Psc5, Original Reports, Treatment-Related Complications